Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
AUTHORS
Yilmaz
TTaygan ,
Weaver
CD Christopher D ,
Gallagher
MJ Micheal J ,
Cordero-Coma
M Miguel ,
Cervantes-Castaneda
RA Rene A ,
Klisovic
D Dino ,
Lavaque
AJ Alejandro J ,
Larson
RJ Robin J .
Ophthalmology. 2009 5 ; 116(5).
902-11; quiz 912-3
- PMID: 19410949[PubMed].
ABSTRACT
To compare intravitreal triamcinolone acetonide (IVTA) injection versus no treatment or sub-Tenon triamcinolone acetonide (STTA) injection in improving visual acuity (VA) of patients with refractory diabetic macular edema (DME; unresponsive to focal laser therapy).
To compare intravitreal triamcinolone acetonide (IVTA) injection versus no treatment or sub-Tenon triamcinolone acetonide (STTA) injection in improving visual acuity (VA) of patients with refractory diabetic macular edema (DME; unresponsive to focal laser therapy).